Reply: Re: Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson's Disease in the UK and Germany

被引：0

作者：

Walter, Evelyn ^{[1
]}

Odin, Per ^{[1
]}

机构：

[1] Hlth Econ, Inst Pharmaecon Res, Vienna, Austria

来源：

JOURNAL OF MEDICAL ECONOMICS | 2015年 / 18卷 / 11期

关键词：

DEEP-BRAIN-STIMULATION; MOTOR FLUCTUATIONS; MEDICAL THERAPY; INFUSION; TRIAL;

D O I：

10.3111/13696998.2015.1074079

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：860 / 862

页数：3

共 50 条

[31] Intermittent Subcutaneous Injections of Apomorphine in Parkinson's Disease
Ceylan, Mustafa
Gultekin, Murat
Celik, Nazli Durmaz
Samanci, Bedia
Cakmakli, Gul Yalcin
Yilmaz, Rezzak
EURASIAN JOURNAL OF MEDICINE, 2022, 54 : S71 - S76
[32] Safety and tolerability of apomorphine sublingual film and subcutaneous apomorphine for the treatment of OFF episodes in Parkinson's disease
Rascol, O.
Poewe, W.
Stocchi, F.
Chaudhuri, R.
Kassube, J.
Manzanares, L. Lopez
Leta, V.
Zhang, I.
Bowling, A.
Wu, S.
Pappert, E.
MOVEMENT DISORDERS, 2022, 37 : S348 - S348
[33] Efficacy of apomorphine sublingual film versus subcutaneous apomorphine for the treatment of OFF episodes in Parkinson's Disease
Stocchi, F.
Rascol, O.
Poewe, W.
Chaudhuri, R.
Kassubek, J.
Manzanares, L. Lopez
Leta, V.
Zhang, I.
Bowling, A.
Wu, S.
Pappert, E.
MOVEMENT DISORDERS, 2022, 37 : S356 - S356
[34] Cost-effectiveness of continuous duodenal delivery of levodopa (Duodopa®) in patients with severe Parkinson's disease
Kristiansen, IS
Bingefors, K
Isacson, D
VALUE IN HEALTH, 2005, 8 (06) : A133 - A134
[35] The cost-effectiveness of continuous duodenal delivery of levodopa (Duodopa®) in patients with severe Parkinson's disease
Kristiansen, IS
Bingefors, C
Nyholm, D
Isacson, D
MOVEMENT DISORDERS, 2005, 20 : S80 - S80
[36] THE COST-EFFECTIVENESS OF CLOZAPINE VS. QUETIAPINE IN THE TREATMENT OF PARKINSON'S DISEASE PSYCHOSIS
Chekani, F.
Sansgiry, S. S.
VALUE IN HEALTH, 2017, 20 (05) : A193 - A193
[37] The cost-effectiveness implications of suboptimal treatment for different severities of Alzheimer's disease in the UK
Zala, Darshan
Chan, Dennis
McCrone, Paul
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 33 (02) : 307 - 315
[38] Cost-effectiveness analysis of pramipexole in early Parkinson's disease
Noyes, K
Dick, AW
Holloway, RG
VALUE IN HEALTH, 2003, 6 (03) : 274 - 274
[39] Apomorphine in the treatment of Parkinson's disease
Menon, Rukmini
Stacy, Mark
EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (12) : 1941 - 1950
[40] The cost-effectiveness of osteogenic protein I in the treatment of tibial nonunions in the UK and Germany
van Engen, AK
Vinken, AG
VALUE IN HEALTH, 2002, 5 (06) : 579 - 579

← 1 2 3 4 5 →